Penczek Ronald W 4

What Happened

• Ronald W. Penczek, Chief Accounting Officer & Controller of Elevance Health (ELV), sold 369 shares in an open-market transaction on June 12, 2026. The reported weighted-average sale price was $403.16 per share, for total proceeds of approximately $148,766. This was a sale (disposition), which is often a routine liquidity event rather than a direct signal about company outlook.

Key Details

• Transaction date: 2026-06-12; reported on Form 4 filed 2026-06-15 (filing appears timely).
• Price: weighted average $403.16; trades ranged from $403.15 to $403.31 (see footnote F1).
• Shares sold: 369; total proceeds ≈ $148,766.
• Shares owned after the transaction: not specified in the provided excerpt (see the full Form 4 for post-transaction holdings).
• Footnote F1: sale executed in multiple trades at prices $403.15–$403.31; the reported price is the weighted average. The reporting person offers to provide trade-level details upon request.

Context

• This was an open-market sale (code S). Sales by executives are common for diversification, tax or personal reasons and do not by themselves indicate management’s view of the company’s prospects. For full ownership details and any other related transactions, review the complete Form 4 filing (Accession: 0001659075-26-000006).